Warning! The directory is not yet complete and will be amended until the beginning of the term.
323008 SE Case Studies in Drug Discovery and Preclinical Drug Development - MPS7 (2024S)
(2 Courses)
Continuous assessment of course work
Labels
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Fr 09.02.2024 19:41 to Mo 01.04.2024 12:00
- Deregistration possible until Mo 01.04.2024 12:00
Details
Language: English
Lecturers
Classes (iCal) - next class is marked with N
Case study schedule is in progress. Please see the Moodle platform for updates and instructions.
Wednesday, 10 April 8:00 - 9:00 (Web-based-Zoom) - All participantsParticipants will be assigned to a Case Study. Information about the Case Studies can be found on Moodle.Case Study 1 (Schedule for Case Study 1 Participants):Thursday 11.04.2024 14:00 - 16:00 (Web-Based-Zoom)
Tuesday 14.05.2024 14:00 - 16:00 (Web-Based-Zoom)
Monday 18.06.2024 09:00 - 11:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II 2D313Case Study 2 (Schedule for Case Study 2 Participants):
Thursday 18.04.2024 8:30 - 10:30 (Web-Based-Zoom)
Tuesday 03.05.2024 8:30 - 10:30 (Web-Based-Zoom)
Monday 10.06.2024 09:00 - 11:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II 2D313Case Study 3 (Schedule for Case Study 3 Participants) - Schedule in progress
- Tuesday 04.06. 14:00 - 16:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
- Monday 10.06. 09:00 - 11:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Information
Aims, contents and method of the course
Students will work in small teams on case studies to conceptualise concrete drug development project proposals, discuss the case study topics and revise their proposals with the supervisors. The case study will involve a real project conducted in industry. The outcomes from the industry research project will be revealed in the final lecture. The course will consist of Introduction to the course, two lectures, 3 assignments, and 3 feedback/discussion teaching sessions.
Assessment and permitted materials
Students must attend all sessions and actively participate in the discussions, complete and submit all of the assignments on time. They are expected to incorporate feedback and discussion outcomes into their revised final project proposal that is due before the last day of class and to actively contribute to research and team activities outside of the lecture periods towards completing assignments and fulfilling the requirements of the course. Students are expected to incorporate and make use of knowledge gained in MPS1-MPS6 of the Master in Drug Discovery program.
Minimum requirements and assessment criteria
Enrollment in the Master of Drug Discovery and Development program and successful completion of MPS1 in the Master of Drug Discovery and Development program are required to attend this course. Course attendance to all sessions, completion of all assignments including revisions from feedback sessions to be submitted to instructors for evaluation on time and the final presentation to be submitted and given on last day of course and final revised proposal to be submitted to instructors, are all minimum requirements for the course.
Examination topics
Team presentation of the finalized project proposal (each team member must present)
Submission of the finalized research proposal and presentation slide deck.
Submission of the finalized research proposal and presentation slide deck.
Reading list
To be given in class
Association in the course directory
Last modified: We 20.03.2024 10:47